Dr. ChiChi Huang joined BeiGene in September 2019 and is the Vice President, Head of Biologics. Prior to joining BeiGene, Dr. Huang has over twenty years of extensive scientific and management experience at Pfizer and Johnson & Johnson, with broad expertise in diverse therapeutic modalities, including monoclonal antibodies, peptides, fusion proteins, and vaccines.

Dr. Huang obtained his doctoral degree in Biochemistry from Tufts University Graduate School of Biomedical Sciences and completed his post-doctoral training at Harvard University Medical School.